These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 9042110)
1. Cytokine production in the brain following closed head injury: dexanabinol (HU-211) is a novel TNF-alpha inhibitor and an effective neuroprotectant. Shohami E; Gallily R; Mechoulam R; Bass R; Ben-Hur T J Neuroimmunol; 1997 Feb; 72(2):169-77. PubMed ID: 9042110 [TBL] [Abstract][Full Text] [Related]
2. 45Ca accumulation in rat brain after closed head injury; attenuation by the novel neuroprotective agent HU-211. Nadler V; Biegon A; Beit-Yannai E; Adamchik J; Shohami E Brain Res; 1995 Jul; 685(1-2):1-11. PubMed ID: 7583233 [TBL] [Abstract][Full Text] [Related]
3. Development of HU-211 as a neuroprotectant for ischemic brain damage. Biegon A; Joseph AB Neurol Res; 1995 Aug; 17(4):275-80. PubMed ID: 7477742 [TBL] [Abstract][Full Text] [Related]
4. Dexanabinol: dexanabinone, HU 211, PA 50211, PRS 211007, sinnabidol. Drugs R D; 2003; 4(3):185-7. PubMed ID: 12757406 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor necrosis factor alpha (TNFalpha) activity in rat brain is associated with cerebroprotection after closed head injury. Shohami E; Bass R; Wallach D; Yamin A; Gallily R J Cereb Blood Flow Metab; 1996 May; 16(3):378-84. PubMed ID: 8621742 [TBL] [Abstract][Full Text] [Related]
6. Antioxidants attenuate acute toxicity of tumor necrosis factor-alpha induced by brain injury in rat. Trembovler V; Beit-Yannai E; Younis F; Gallily R; Horowitz M; Shohami E J Interferon Cytokine Res; 1999 Jul; 19(7):791-5. PubMed ID: 10454350 [TBL] [Abstract][Full Text] [Related]
7. Dexanabinol; a novel neuroprotective drug in experimental focal cerebral ischemia. Leker RR; Shohami E; Abramsky O; Ovadia H J Neurol Sci; 1999 Jan; 162(2):114-9. PubMed ID: 10202976 [TBL] [Abstract][Full Text] [Related]
8. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Shohami E; Novikov M; Bass R Brain Res; 1995 Mar; 674(1):55-62. PubMed ID: 7773695 [TBL] [Abstract][Full Text] [Related]
9. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. Stahel PF; Shohami E; Younis FM; Kariya K; Otto VI; Lenzlinger PM; Grosjean MB; Eugster HP; Trentz O; Kossmann T; Morganti-Kossmann MC J Cereb Blood Flow Metab; 2000 Feb; 20(2):369-80. PubMed ID: 10698075 [TBL] [Abstract][Full Text] [Related]
10. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. Yatsiv I; Morganti-Kossmann MC; Perez D; Dinarello CA; Novick D; Rubinstein M; Otto VI; Rancan M; Kossmann T; Redaelli CA; Trentz O; Shohami E; Stahel PF J Cereb Blood Flow Metab; 2002 Aug; 22(8):971-8. PubMed ID: 12172382 [TBL] [Abstract][Full Text] [Related]
11. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Tuttolomondo A; Pecoraro R; Pinto A Drug Des Devel Ther; 2014; 8():2221-38. PubMed ID: 25422582 [TBL] [Abstract][Full Text] [Related]
13. Gallic acid improved behavior, brain electrophysiology, and inflammation in a rat model of traumatic brain injury. Sarkaki A; Farbood Y; Gharib-Naseri MK; Badavi M; Mansouri MT; Haghparast A; Mirshekar MA Can J Physiol Pharmacol; 2015 Aug; 93(8):687-94. PubMed ID: 26222320 [TBL] [Abstract][Full Text] [Related]
14. D-cycloserine improves functional recovery and reinstates long-term potentiation (LTP) in a mouse model of closed head injury. Yaka R; Biegon A; Grigoriadis N; Simeonidou C; Grigoriadis S; Alexandrovich AG; Matzner H; Schumann J; Trembovler V; Tsenter J; Shohami E FASEB J; 2007 Jul; 21(9):2033-41. PubMed ID: 17351125 [TBL] [Abstract][Full Text] [Related]
15. Neuroprotective activity of HU-211, a novel nonpsychotropic synthetic cannabinoid. Biegon A Ann N Y Acad Sci; 1995 Sep; 765():314. PubMed ID: 7486626 [No Abstract] [Full Text] [Related]
16. Protection against septic shock and suppression of tumor necrosis factor alpha and nitric oxide production by dexanabinol (HU-211), a nonpsychotropic cannabinoid. Gallily R; Yamin A; Waksmann Y; Ovadia H; Weidenfeld J; Bar-Joseph A; Biegon A; Mechoulam R; Shohami E J Pharmacol Exp Ther; 1997 Nov; 283(2):918-24. PubMed ID: 9353414 [TBL] [Abstract][Full Text] [Related]
17. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. Tehranian R; Andell-Jonsson S; Beni SM; Yatsiv I; Shohami E; Bartfai T; Lundkvist J; Iverfeldt K J Neurotrauma; 2002 Aug; 19(8):939-51. PubMed ID: 12225654 [TBL] [Abstract][Full Text] [Related]
18. Dexanabinol (HU-211) has a beneficial effect on axonal sprouting and survival after rat optic nerve crush injury. Zalish M; Lavie V Vision Res; 2003 Feb; 43(3):237-42. PubMed ID: 12535983 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 and tumor necrosis factor-alpha synergistically mediate neurotoxicity: involvement of nitric oxide and of N-methyl-D-aspartate receptors. Chao CC; Hu S; Ehrlich L; Peterson PK Brain Behav Immun; 1995 Dec; 9(4):355-65. PubMed ID: 8903852 [TBL] [Abstract][Full Text] [Related]
20. Lacosamide improves outcome in a murine model of traumatic brain injury. Wang B; Dawson H; Wang H; Kernagis D; Kolls BJ; Yao L; Laskowitz DT Neurocrit Care; 2013 Aug; 19(1):125-34. PubMed ID: 23269559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]